Join us in returning to NYC on June 5th to collaborate with executive leaders in exploring comprehensive methods for auditing AI models regarding bias, performance, and ethical compliance across diverse organizations. Find out how you can attend here.
As many continue to debate the role of AI in healthcare, startups are going all in on the technology – with the full support of venture capital firms. Today, San Francisco-based Triomics, a startup looking to accelerate cancer care with generative AI, announced its $15 million from Lightspeed, Nexus Venture Partners, General Catalyst and Y Combinator.
Founded by former MIT and Adobe researchers Sarim Khan and Hrituraj Singh, Triomics has developed a family of large language models (LLMs), dubbed OncoLLM, that streamlines the complex and time-consuming oncology-related workflows staffers at medical centers have to go through to determine the right treatment path for a patient.
The models work with a set of workflow-specific tools and have been proven to do tasks that would usually take days or weeks in just minutes.
“We have successfully merged expertise in two complex functional areas: our AI researchers, who are specialized in customizing language models to specific domains, and our clinical staff, who have decades of oncology-specific experience. As a result, our software can complement the strengths of these advanced models while also proactively addressing potential flaws, all with the intricacies of cancer research and care in mind,” Singh said in a statement.
VB Event
The AI Impact Tour: The AI Audit
Join us as we return to NYC on June 5th to engage with top executive leaders, delving into strategies for auditing AI models to ensure fairness, optimal perf …
Article Attribution | Read More at Article Source
Join us in returning to NYC on June 5th to collaborate with executive leaders in exploring comprehensive methods for auditing AI models regarding bias, performance, and ethical compliance across diverse organizations. Find out how you can attend here.
As many continue to debate the role of AI in healthcare, startups are going all in on the technology – with the full support of venture capital firms. Today, San Francisco-based Triomics, a startup looking to accelerate cancer care with generative AI, announced its $15 million from Lightspeed, Nexus Venture Partners, General Catalyst and Y Combinator.
Founded by former MIT and Adobe researchers Sarim Khan and Hrituraj Singh, Triomics has developed a family of large language models (LLMs), dubbed OncoLLM, that streamlines the complex and time-consuming oncology-related workflows staffers at medical centers have to go through to determine the right treatment path for a patient.
The models work with a set of workflow-specific tools and have been proven to do tasks that would usually take days or weeks in just minutes.
“We have successfully merged expertise in two complex functional areas: our AI researchers, who are specialized in customizing language models to specific domains, and our clinical staff, who have decades of oncology-specific experience. As a result, our software can complement the strengths of these advanced models while also proactively addressing potential flaws, all with the intricacies of cancer research and care in mind,” Singh said in a statement.
VB Event
The AI Impact Tour: The AI Audit
Join us as we return to NYC on June 5th to engage with top executive leaders, delving into strategies for auditing AI models to ensure fairness, optimal perf …nnDiscussion:nn” ai_name=”RocketNews AI: ” start_sentence=”Can I tell you more about this article?” text_input_placeholder=”Type ‘Yes'”]